We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
182 hedge funds and large institutions have $1.51B invested in Oric Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 57 increasing their positions, 63 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
86% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 22
54% more capital invested
Capital invested by funds: $980M → $1.51B (+$530M)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% more funds holding
Funds holding: 164 → 182 (+18)
8% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $959K
10% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 63
3.93% less ownership
Funds ownership: 122.86% → 118.93% (-3.9%)
Holders
182
Holders Change
+18
Holders Change %
+10.98%
% of All Funds
2.24%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.09%
New
41
Increased
57
Reduced
63
Closed
22
Calls
$1.04M
Puts
$959K
Net Calls
+$80K
Net Calls Change
-$168K
Top Buyers
| 1 |
ACM
AIHC Capital Management
Central,
|
+$27.9M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.8M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$22.6M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$12.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$11.4M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$23.9M |
| 2 |
VA
VR Adviser
New York
|
-$15.4M |
| 3 |
O
OrbiMed
New York
|
-$10.8M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$8.49M |
| 5 |
Barclays
London,
United Kingdom
|
-$8.02M |
